ATP7A Gene Menkes Disease NGS Genetic DNA Test
Introduction
The ATP7A Gene Menkes Disease NGS Genetic DNA Test is a pivotal diagnostic tool that identifies mutations in the ATP7A gene, which are responsible for Menkes disease. This rare genetic disorder significantly impacts copper metabolism, leading to severe neurological and developmental issues. Early diagnosis through this test is crucial for effective management and intervention.
What the Test Measures
This genetic test utilizes Next Generation Sequencing (NGS) technology to detect specific mutations in the ATP7A gene. By analyzing the genetic material, healthcare providers can confirm the presence of Menkes disease and assess the risk of transmission to offspring.
Who Should Consider This Test
Individuals who may benefit from the ATP7A Gene Menkes Disease NGS Genetic DNA Test include:
- Infants and children exhibiting developmental delays, seizures, or neurological symptoms.
- Families with a history of Menkes disease or related genetic disorders.
- Individuals with symptoms suggestive of copper metabolism disorders.
Benefits of Taking the Test
Understanding your genetic predisposition can lead to:
- Early intervention and tailored treatment plans.
- Informed family planning and genetic counseling.
- Better management of symptoms and health outcomes.
Understanding Your Results
Results from the ATP7A Gene Menkes Disease NGS Genetic DNA Test typically take 3 to 4 weeks. A genetic counselor will assist in interpreting the results, discussing potential implications, and planning further actions based on the findings.
Test Name and Pricing
| Test Name | Discount Price | Regular Price |
|---|---|---|
| ATP7A Gene Menkes Disease NGS Genetic DNA Test | 40,000 KSh | 56,000 KSh |
Book Your Test Today!
We have branches across all major cities in Kenya, and we also offer a home sample collection service for your convenience. To book the ATP7A Gene Menkes Disease NGS Genetic DNA Test, please call or WhatsApp us at +254711564616. Don’t wait—secure your health today!
